EUVIMEDEUVIMED entdecken
Crossref

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation

Frederic Schorsch iD, Mirjam Luijten, Mark Cronin iD, Heidrun Ellinger-Ziegelbauer iD, Kelly Evans iD, Joanne Elloway

Toxicologic Pathology · 2026-07 · 54 (5) · 380-384

DOI: 10.1177/01926233261455035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 29.06.2026. Verfasst von Frederic Schorsch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bayer SAS Crop Science Division, Sophia Antipolis, France. Hauptthemen laut MEDLINE: Carcinogens. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The second session of the 2nd Joint BSTP/ESTP Toxicologic Pathology Congress, Manchester, UK, September 23-26, 2025, entitled “New Approach Methodologies for Carcinogenicity Evaluation,” was dedicated to innovative strategies for assessing carcinogenic risks in various substances, particularly in drug development and agrochemicals. The two-year rodent cancer bioassay in two species (generally rats and mice) is currently the standard method for assessing the carcinogenic potential of agrochemicals for humans. However, this method has some weaknesses and is subject to ethical and scientific debate. Attempts to waive those studies have been proposed, but more relevant methods using less or preferably no animals are still being sought. The session featured five key presentations that explored cutting-edge methodologies aimed at improving the accuracy and reliability of carcinogenicity predictions. Below is a summary of each talk presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogensCarcinogenicity TestsAnimalsHumansRisk AssessmentMiceRats

Stichwörter der Autor:innen

3RsNAMscarcinogenicityrisk assessment

Substanzen

Carcinogens

Autor:innen und Institutionen

  • Bayer SAS Crop Science Division, Sophia Antipolis, France.
  • National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Liverpool John Moores University, Liverpool, UK.
  • Bayer AG, Wuppertal, Germany.
  • AstraZeneca, Cambridge, UK.

ORCID-Profile: Frederic Schorsch, Mark Cronin, Heidrun Ellinger-Ziegelbauer, Kelly Evans

Zitieren

APA

Schorsch, F., Luijten, M., Cronin, M., Ellinger-Ziegelbauer, H., Evans, K., & Elloway, J. (2026). New Approach Methodologies (NAMs) for Carcinogenicity Evaluation. Toxicologic Pathology, 54(5), 380-384. https://doi.org/10.1177/01926233261455035

Vancouver

Schorsch F, Luijten M, Cronin M, Ellinger-Ziegelbauer H, Evans K, Elloway J. New Approach Methodologies (NAMs) for Carcinogenicity Evaluation. Toxicologic Pathology. 2026;54(5):380-384. doi:10.1177/01926233261455035

BibTeX
@article{Schorsch2026,
  author = {Schorsch, Frederic and Luijten, Mirjam and Cronin, Mark and Ellinger-Ziegelbauer, Heidrun and Evans, Kelly and Elloway, Joanne},
  title = {New Approach Methodologies (NAMs) for Carcinogenicity Evaluation},
  journal = {Toxicologic Pathology},
  year = {2026},
  volume = {54},
  number = {5},
  pages = {380--384},
  doi = {10.1177/01926233261455035}
}
Kostenlos starten →